Diabetes herbals recalled
This article was originally published in The Tan Sheet
Executive Summary
Two California firms announce March 23 they have initiated recalls of herbal supplements containing a prescription drug used to treat diabetes. SciQuest Lab's Dimelstat and Diabetic Capital's Dianolyn Capsules contain glyburide, a blood sugar-lowering medication that could cause "life-threatening complications" for diabetes patients, the companies acknowledge. Dianolyn is manufactured in China and then packaged and distributed in the U.S., Diabetic Capital explains. In February, the California Department of Health Services' Food & Drug Branch and FDA prompted a recall of two other supplements that contained glyburide and phenformin (1"The Tan Sheet" Feb. 21, p. 9)